Using Microscale Thermophoresis to Characterize Hits from High-Throughput Screening

A European Lead Factory Perspective

Julie M. Rainard, George C. Pandarakalam, Stuart P. McElroy (Lead / Corresponding author)

Research output: Contribution to journalReview article

4 Citations (Scopus)
157 Downloads (Pure)

Abstract

High-throughput screening (HTS) is a proven method for discovering new lead matter for drug discovery and chemical biology. To maximize the likelihood of identifying genuine binders to a molecular target, and avoid wasting resources following up compounds with unproductive/nonspecific mechanisms of action, it is important to employ a range of assays during an HTS campaign that build confidence of target engagement for hit compounds. Biophysical methods that measure direct target/compound engagement have established themselves as key techniques in generating this confidence, and they are now integral to the latter stages of HTS triage at the European Lead Factory (ELF). One relatively new technique that the ELF is using is microscale thermophoresis (MST), which measures the differences in rate of movement through a temperature gradient that are caused when single molecular species form complexes. Here we provide an overview of the MST assay development workflow that the ELF employs and a perspective of our experience to date of using MST to triage the output of HTS campaigns and how it compares and contrasts with the use of other biophysical techniques.

Original languageEnglish
Pages (from-to)225-241
Number of pages17
JournalSLAS Discovery
Volume23
Issue number3
Early online date20 Feb 2018
DOIs
Publication statusPublished - 1 Mar 2018

Fingerprint

Thermophoresis
Industrial plants
Screening
Throughput
Triage
Assays
High-Throughput Screening Assays
Workflow
Drug Discovery
Thermal gradients
Binders
Temperature
Lead

Keywords

  • assay development
  • biophysical assays
  • drug discovery
  • high-throughput screening
  • microscale thermophoresis

Cite this

@article{ec8775cee0044c1f8e52228f7d27b805,
title = "Using Microscale Thermophoresis to Characterize Hits from High-Throughput Screening: A European Lead Factory Perspective",
abstract = "High-throughput screening (HTS) is a proven method for discovering new lead matter for drug discovery and chemical biology. To maximize the likelihood of identifying genuine binders to a molecular target, and avoid wasting resources following up compounds with unproductive/nonspecific mechanisms of action, it is important to employ a range of assays during an HTS campaign that build confidence of target engagement for hit compounds. Biophysical methods that measure direct target/compound engagement have established themselves as key techniques in generating this confidence, and they are now integral to the latter stages of HTS triage at the European Lead Factory (ELF). One relatively new technique that the ELF is using is microscale thermophoresis (MST), which measures the differences in rate of movement through a temperature gradient that are caused when single molecular species form complexes. Here we provide an overview of the MST assay development workflow that the ELF employs and a perspective of our experience to date of using MST to triage the output of HTS campaigns and how it compares and contrasts with the use of other biophysical techniques.",
keywords = "assay development, biophysical assays, drug discovery, high-throughput screening, microscale thermophoresis",
author = "Rainard, {Julie M.} and Pandarakalam, {George C.} and McElroy, {Stuart P.}",
note = "No funding",
year = "2018",
month = "3",
day = "1",
doi = "10.1177/2472555217744728",
language = "English",
volume = "23",
pages = "225--241",
journal = "SLAS Discovery",
issn = "2472-5552",
publisher = "SAGE Publications",
number = "3",

}

TY - JOUR

T1 - Using Microscale Thermophoresis to Characterize Hits from High-Throughput Screening

T2 - A European Lead Factory Perspective

AU - Rainard, Julie M.

AU - Pandarakalam, George C.

AU - McElroy, Stuart P.

N1 - No funding

PY - 2018/3/1

Y1 - 2018/3/1

N2 - High-throughput screening (HTS) is a proven method for discovering new lead matter for drug discovery and chemical biology. To maximize the likelihood of identifying genuine binders to a molecular target, and avoid wasting resources following up compounds with unproductive/nonspecific mechanisms of action, it is important to employ a range of assays during an HTS campaign that build confidence of target engagement for hit compounds. Biophysical methods that measure direct target/compound engagement have established themselves as key techniques in generating this confidence, and they are now integral to the latter stages of HTS triage at the European Lead Factory (ELF). One relatively new technique that the ELF is using is microscale thermophoresis (MST), which measures the differences in rate of movement through a temperature gradient that are caused when single molecular species form complexes. Here we provide an overview of the MST assay development workflow that the ELF employs and a perspective of our experience to date of using MST to triage the output of HTS campaigns and how it compares and contrasts with the use of other biophysical techniques.

AB - High-throughput screening (HTS) is a proven method for discovering new lead matter for drug discovery and chemical biology. To maximize the likelihood of identifying genuine binders to a molecular target, and avoid wasting resources following up compounds with unproductive/nonspecific mechanisms of action, it is important to employ a range of assays during an HTS campaign that build confidence of target engagement for hit compounds. Biophysical methods that measure direct target/compound engagement have established themselves as key techniques in generating this confidence, and they are now integral to the latter stages of HTS triage at the European Lead Factory (ELF). One relatively new technique that the ELF is using is microscale thermophoresis (MST), which measures the differences in rate of movement through a temperature gradient that are caused when single molecular species form complexes. Here we provide an overview of the MST assay development workflow that the ELF employs and a perspective of our experience to date of using MST to triage the output of HTS campaigns and how it compares and contrasts with the use of other biophysical techniques.

KW - assay development

KW - biophysical assays

KW - drug discovery

KW - high-throughput screening

KW - microscale thermophoresis

UR - http://www.scopus.com/inward/record.url?scp=85042482006&partnerID=8YFLogxK

U2 - 10.1177/2472555217744728

DO - 10.1177/2472555217744728

M3 - Review article

VL - 23

SP - 225

EP - 241

JO - SLAS Discovery

JF - SLAS Discovery

SN - 2472-5552

IS - 3

ER -